Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 42 Records) |
Query Trace: Glioblastoma and PTEN[original query] |
---|
Germline MSH6 Mutation in a Patient With Two Independent Primary Glioblastomas. Journal of neuropathology and experimental neurology 2017 9 76 (10): 848-853. Forsström Linda M, Sumi Koichiro, Mäkinen Markus J, Oh Ji Eun, Herva Riitta, Kleihues Paul, Ohgaki Hiroko, Aaltonen Lauri |
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas. Neoplasma 2018 Mar 65 (3): 431-435. Han S, Wang P F, Xing Y X, Song H W, Yao K, Lin Z |
Significant Effect of Anti-tyrosine Kinase Inhibitor (Gefitinib) on Overall Survival of the Glioblastoma Multiforme Patients in the Backdrop of Mutational Status of Epidermal Growth Factor Receptor and PTEN Genes. Asian journal of neurosurgery 0 13 (1): 46-52. Arif Sajad Hussain, Pandith Arshad Ahmad, Tabasum Rehana, Ramzan Altaf Umar, Singh Sarabjeet, Siddiqi Mushtaq Ahmad, Bhat Abdul Rash |
WITHDRAWAL: Significant effect of anti-tyrosine kinase inhibitor (Gefitinib) on overall survival of the Glioblastoma (GBM) patients in the backdrop of mutational status of EGFR and PTEN genes. Journal of neurosurgical sciences 2018 Feb . Arif Sajad H, Pandith Arshad A, Tabasum Rehana, Ramzan Altaf U, Singh Sarabjeet, Siddiqi Mushtaq A, Bhat Abdul |
Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes. Gene 2018 11 685 85-95. Patil Vikas, Mahalingam Kulandaive |
Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature. Cancers 2019 Feb 11 (3): . Wojtas Bartosz, Gielniewski Bartlomiej, Wojnicki Kamil, Maleszewska Marta, Mondal Shamba S, Nauman Pawel, Grajkowska Wieslawa, Glass Rainer, Schüller Ulrich, Herold-Mende Christel, Kaminska Boze |
Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas. Aging 2019 12 11 (23): 11224-11243. Yang Chao, Tan Yanli, Li Shouwei, Zhou Junhu, Wang Qixue, Wang Yunfei, Xie Yingbin, Chen Luyue, Li Jie, Fang Chuan, Kang Chunshe |
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas. Journal of translational medicine 2020 Aug 18 (1): 305. Zhang Hao, Fan Fan, Yu Yuanqiang, Wang Zeyu, Liu Fangkun, Dai Ziyu, Zhang Liyang, Liu Zhixiong, Cheng Qu |
Establishment and validation of an immune-based prognostic score model in glioblastoma. International immunopharmacology 2020 6 85 106636. Qin Zhigang, Zhang Xiuli, Chen Zhuo, Liu Naij |
Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches. Journal of oncology 2019 2019 4878547. Ellis H P, McInerney C E, Schrimpf D, Sahm F, Stupnikov A, Wadsley M, Wragg C, White P, Prise K M, McArt D G, Kurian K |
Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma. Neoplasia (New York, N.Y.) 2020 11 22 (12): 800-808. Stasik Sebastian, Juratli Tareq A, Petzold Andreas, Richter Sven, Zolal Amir, Schackert Gabriele, Dahl Andreas, Krex Dietmar, Thiede Christi |
Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population. PloS one 2020 11 15 (11): e0242793. Saadeh Fadi S, Morsi Rami Z, El-Kurdi Abdallah, Nemer Georges, Mahfouz Rami, Charafeddine Maya, Khoury Jessica, Najjar Marwan W, Khoueiry Pierre, Assi Hazem |
TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma. Neuro-oncology advances 2020 11 2 (1): vdaa114. Kikuchi Zensho, Shibahara Ichiyo, Yamaki Tetsu, Yoshioka Ema, Shofuda Tomoko, Ohe Rintaro, Matsuda Ken-Ichiro, Saito Ryuta, Kanamori Masayuki, Kanemura Yonehiro, Kumabe Toshihiro, Tominaga Teiji, Sonoda Yukihi |
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 10 26 (24): 6600-6609. Carrato Cristina, Alameda Francesc, Esteve-Codina Anna, Pineda Estela, Arpí Oriol, Martinez-García Maria, Mallo Mar, Gut Marta, Lopez-Martos Raquel, Barco Sonia Del, Ribalta Teresa, Capellades Jaume, Puig Josep, Gallego Oscar, Mesia Carlos, Muñoz-Marmol Ana M, Archilla Ivan, Arumí Montserrat, Blanc Julie Marie, Bellosillo Beatriz, Menendez Silvia, Esteve Anna, Bagué Silvia, Hernandez Ainhoa, Craven-Bartle Jordi, Fuentes Rafael, Vidal Noemí, Aldecoa Iban, Iglesia Nuria de la, Balana Carm |
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
Next-Generation Sequencing in the Diagnosis of Metastatic Lesions: Reclassification of a Glioblastoma as an Endometrial Cancer Metastasis to the Brain. The oncologist 2021 Aug . Leung Shuk On Annie, Foley Olivia, Chapel David, Da Silva Annacarolina, Nucci Marisa, Muto Michael G, Campos Susa |
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy. Frontiers in oncology 2021 11 640910. Hu Li, Cheng Xingbo, Binder Zev, Han Zhibin, Yin Yibo, O'Rourke Donald M, Wang Sida, Feng Yumeng, Weng Changjiang, Wu Anhua, Lin Zhig |
Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer management and research 2021 5 13 3573-3588. Zeng Chun, Wang Jing, Li Mingwei, Wang Huina, Lou Feng, Cao Shanbo, Lu Chang |
Molecular Characterization of "True" Low-Grade IDH-Wildtype Astrocytomas. Journal of neuropathology and experimental neurology 2021 4 80 (5): 431-435. Richardson Timothy E, Hatanpaa Kimmo J, Walker Jamie |
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma. Cell death & disease 2021 4 12 (4): 374. Choi Seung Won, Lee Yeri, Shin Kayoung, Koo Harim, Kim Donggeon, Sa Jason K, Cho Hee Jin, Shin Hye-Mi, Lee Se Jeong, Kim Hyunho, Chung Seok, Shin Jihye, Lee Cheolju, Nam Do-Hy |
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation. Acta neuropathologica communications 2021 12 9 (1): 200. Barresi Valeria, Simbolo Michele, Mafficini Andrea, Martini Maurizio, Calicchia Martina, Piredda Maria Liliana, Ciaparrone Chiara, Bonizzato Giada, Ammendola Serena, Caffo Maria, Pinna Giampietro, Sala Francesco, Lawlor Rita Teresa, Ghimenton Claudio, Scarpa Al |
A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma. Neuro-oncology advances 2022 2 4 (1): vdac002. Yang Peter H, Tao Yu, Luo Jingqin, Paturu Mounica, Lu Hsiang-Chih, Ramkissoon Shakti, Heusel Jonathan W, Leuthardt Eric C, Chicoine Michael R, Dowling Joshua L, Dunn Gavin P, Duncavage Eric, Dahiya Sonika, Chattherjee Arindam R, Kim Albert |
Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study. Thrombosis research 2022 11 221 10-18. Kapteijn Maaike Y, Kaptein Fleur H J, Stals Milou A M, Klaase Eva E, García-Ortiz Inés, van Eijk Ronald, Ruano Dina, van Duinen Sjoerd G, Cannegieter Suzanne C, Taphoorn Martin J B, Dirven Linda, Koekkoek Johan A F, Klok Frederikus A, Versteeg Henri H, Buijs Jeroen |
Landscape of Genomic Alterations in IDH Wild-Type Glioblastoma Identifies PI3K as a Favorable Prognostic Factor. JCO precision oncology 2022 1 4 575-584. Yan Yuanqing, Takayasu Takeshi, Hines Gabriella, Dono Antonio, Hsu Sigmund H, Zhu Jay-Jiguang, Riascos-Castaneda Roy F, Kamali Arash, Bhattacharjee Meenakshi B, Blanco Angel I, Tandon Nitin, Kim Dong H, Ballester Leomar Y, Esquenazi And Yosh |
Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis. Medical oncology (Northwood, London, England) 2023 4 40 (6): 161. Haofuzi Zhang, Mingdong Bao, Dan Liao, Zhuoyuan Zhang, Zhicheng Tian, Erwan Yang, Peng Luo, Xiaofan Jia |
The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma. Journal of neuroimmunology 2023 2 376 578034. Yu Jiayin, Lai Mingyao, Zhou Zhaoming, Zhou Jiangfen, Hu Qingjun, Li Juan, Li Hainan, Chen Longhua, Wen Lei, Zhou Meijuan, Cai Lin |
Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism. Frontiers in molecular biosciences 2023 1 9 1027236. Liu Zhihui, Wu Jiasheng, Ji Hang, Zhao Hongtao, Wang Fang, Dong Jiawei, Zhang Jiheng, Wang Nan, Yan Xiuwei, Wang Kaikai, Hu Shaosh |
Investigating the effects of PTEN mutations on cGAS-STING pathway in glioblastoma tumours. Journal of neuro-oncology 2024 1 . Eda Dogan, Zafer Yildirim, Taner Akalin, Erkin Ozgiray, Nevhis Akinturk, Cagdas Aktan, Asli Ece Solmaz, Huseyin Biceroglu, Kadri Emre Caliskan, Yesim Ertan, Taskin Yurtseven, Buket Kosova, Vildan Boz |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: